Rising Demand for Blood Components and Need for Blood Transfusion in Therapy to Drive Growth in the Global Apheresis Equipment Market
The
global Apheresis Equipment market is projected to reach US$3.6 billion by 2024,
driven by the increasing prevalence of blood disorders and chronic diseases
requiring blood transfusion.
Apheresis
refers to a procedure where blood from a person (patient or donor) is passed
through a medical device in order to extract the required components, such as
red blood cells, platelets, plasma and others. Apart from its use in separating
specific blood components from donor blood, the apheresis process is also
utilized for the treatment of specific diseases conditions such as leukemia. Global
market for apheresis equipment continues to witness stable growth driven by the
rising adoption of therapeutic and donor apheresis. The increasing prevalence
of blood disorders such as sickle cell anemia, blood cancer, and hemophilia and
the rising need for various blood products is driving the demand for apheresis
equipment, globally. Specifically, the increasing incidence of various
illnesses in the elderly and the subsequent rise in demand for blood and blood
components is expected to foster market growth.
Growing
awareness about platelet donation in developed economies and the subsequent
growth in the number of platelet donors and increasing R&D investments of
biopharmaceutical companies also contribute to apheresis market growth. Also
driving growth is the increase in causality figures that is leading to enhanced
need for surgical procedures that require blood transfusion. Rising awareness
about apheresis blood collection and escalating demand for automated
blood component separation procedures also favor growth in the apheresis
equipment market. Technology advances such as automated interface system, continuous
flow centrifugation and features such as screen navigation, GUI display, and
custom anticoagulant infusion system are also expected to foster growth in the
apheresis equipment market.
As
stated by the new market research report on Apheresis
Equipment, the United States represents the largest regional market,
worldwide. Growth in the US apheresis equipment market is driven by the rising
incidence of hematological disorders and other chronic conditions such as
neurological disorders and increasing demand for technologically advanced and
automated products. Further, access to advanced healthcare services and
favorable reimbursement framework also favors market growth. Asia-Pacific is
forecast to grow at the fastest CAGR of 12.1% over the analysis period. The
promising outlook for Asia-Pacific is attributed to the rising prevalence of
blood-related disorders in emerging economies of China and India. Increase in
surgical procedures and trauma and accident cases and improving healthcare
infrastructure also bode well for the market.
Major
players in the market include Asahi Kasei Medical Co., Ltd., B Braun Melsungen
AG, Cerus Corporation, Fresenius Kabi AG, Haemonetics Corporation, Kaneka
Corporation, Kawasumi Laboratories, Inc., Mallinckrodt Pharmaceuticals, Medica
SpA, NIKKISO Europe GmbH, and Terumo BCT Inc., among others.
The
research report titled “Apheresis
Equipment – Market Analysis, Trends, and Forecasts” announced by Global Industry Analysts Inc., provides a comprehensive review of market
trends, issues, drivers, mergers, acquisitions and other strategic industry
activities of global companies. The report provides market estimates and
projections for all major geographic markets such as the US, Canada, Japan,
Europe (France, Germany, Italy, UK, Spain and Rest of Europe), Asia-Pacific (Australia,
China and Rest of Asia-Pacific) and Rest of World. The market is analyzed by
the product segments - Equipment for Therapeutic Apheresis and Equipment for
Donor Apheresis. Global market for Apheresis Equipment is additionally analyzed
by Procedure – Photopheresis, Plasmapheresis and Others. Further, the US market
is analyzed by the Therapeutic Area – Neurology, Hematology & Oncology,
Rheumatology, and Others (Includes GvHD, Solid Organ Transplant Rejection,
Inflammatory Bowel Disease, Mastocytosis, Pemphigus Vulgaris, and Hepatitis C).
Global Industry
Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
For cutting edge analyst reviews on top
industries, follow us on Twitter
and connect with us on LinkedIn
Comments
Post a Comment